about the institute
The CMR International Institute for Regulatory Science (the Institute) is the vehicle through which the international pharmaceutical industry, regulatory authorities and academia meet, debate and develop regulatory policy. The objectives of the Institute are to facilitate dialogue and productive discussions in order to promote better understanding of the science that will form the basis for regulatory policy; to play an active and pro-active role in the evolution and harmonisation of international regulatory requirements and approval procedures to act as a catalyst for the adoption of best practice in global regulatory affairs; to provide a neutral, professional forum through which peers can meet and share best practice; and to pursue research that supports the Institute's mission.

The work programme for the Institute for 2009 is set out in the Agenda.
learning & developing
29–30 September 2009: Review and Reimbursement — A special case for better cooperation A collaborative workshop between CMR International Institute for Regulatory Science and the Office of Health Economics in the UK
Woodlands Park Hotel, Surrey, UK
registration...
23-24 November 2009: Emerging Markets — Ethnic Factors in Drug Development
Grand Kempinski Hotel, Geneva, Switzerland
registration...
research activities
Benchmarking the Regulatory Review Process


Scorecards: Building Quality into Regulatory Submission and Review


Benefit-Risk Assessment of Medicines


Emerging Markets
members-only

Restricted—access reports and research available to Institute members only